Metagenomi, Inc. (NASDAQ: MGX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT METAGENOMI, INC.

Metagenomi, Inc. (NASDAQ: MGX)
Listen to this Section


$2.69
+0.1350 ( +5.29% ) 306.1K

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Market Data


Open $2.69
Previous Close $2.55
Volume 306.1K
Market Cap $96.39M
Day Range $2.57 - $2.77
52 Week Range $1.61 - $12.74
Shares Outstanding 37.42M
Change % +5.29%
Net Change ▲ 0.1350
Insider Ownership 0.00%
Exchange NASDAQ
Sector Miscellaneous
Industry None
IPO Year 2024
Country United States
Under Writer J.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities, BMO Capital Markets, Chardan Capital Markets, more

Insider Ownership Transactions

Total Amount Purchased: -355,899.00

Date Type Amount Purchased Purchaser
2024-04-03 Sale -57763.00 Noonberg Sarah B.
2024-04-03 Sale -69316.00 Wapnick Pamela
2024-04-03 Sale -10397.00 Wein Matthew
2024-04-03 Sale -69316.00 Borges Luis
2024-04-03 Sale -78636.00 Eckhardt Juergen
2024-04-03 Sale -70471.00 Irish Jian

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Dec 10, 2024
4 Insider transactions 1 Dec 06, 2024
10-q Quarterly Reports 60 Nov 13, 2024
8-k 8K-related 13 Nov 13, 2024
4 Insider transactions 1 Sep 06, 2024
8-k 8K-related 13 Sep 03, 2024
8-k 8K-related 13 Aug 14, 2024
10-q Quarterly Reports 62 Aug 14, 2024
8-k 8K-related 37 May 14, 2024
10-q Quarterly Reports 58 May 14, 2024

Latest News


× Before browsing our site, please accept our cookies policy